The Utility of Radiologic Imaging and Full Body Skin Examination in Patients With Melanoma of Unknown Primary
- PMID: 38957829
- PMCID: PMC11218534
- DOI: 10.7759/cureus.58523
The Utility of Radiologic Imaging and Full Body Skin Examination in Patients With Melanoma of Unknown Primary
Abstract
Although most melanomas have a cutaneous origin, melanomas are rarely discovered without an overt primary site and are found in the metastatic stage. This phenomenon is called melanoma of unknown primary (MUP), which was first recorded in 1963.Melanoma can also rarely present as tumoral melanosis, which has completely regressed. By definition, this does not have viable melanocytes and histologically presents as an infiltration of melanophages and melanin. A 71-year-old female presented for dermatologic evaluation after being found to have melanoma of unknown primary (MUP). The MUP, located in multiple lymph nodes of the left superior and inferior inguinal region, was found on preoperative imaging indicated for surgical management of endometrial carcinoma. After the biopsy, a positron emission tomography-computed tomography (PET-CT) scan was performed to determine the extent of involvement, which noted focal uptake of the left heel of just medial to midline with an SUV max of 2.1. Based on the PET-CT findings, the patient was questioned about the lesion on her heel. She had suspected this was due to friction and stated it had been asymptomatic and present for years. This unique case demonstrates that combined total skin examination and whole-body radiologic imaging (preferably PET-CT) are both critical elements in the evaluation of MUP. Since melanoma of unknown primary is at least American Joint Committee on Cancer (AJCC) 8 Stage III (due to N1 status), imaging is reasonable in these patients.
Keywords: dermatology; melanoma; melanoma of unknown primary; pet-ct; tumoral melanosis.
Copyright © 2024, ShamaeiZadeh et al.
Conflict of interest statement
Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Merkel Cell Carcinoma of Unknown Primary Origin.Acta Dermatovenerol Croat. 2023 Dec;31(3):153-155. Acta Dermatovenerol Croat. 2023. PMID: 38439727
-
Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study.Front Oncol. 2021 Mar 5;11:627527. doi: 10.3389/fonc.2021.627527. eCollection 2021. Front Oncol. 2021. PMID: 33747946 Free PMC article.
-
Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.J Adv Pract Oncol. 2012 May;3(3):161-9. doi: 10.6004/jadpro.2012.3.3.4. J Adv Pract Oncol. 2012. PMID: 25031942 Free PMC article.
-
Tumoral Melanosis in the Setting of Targeted Immunotherapy for Metastatic Melanoma-A Single Institutional Experience and Literature Review.Am J Dermatopathol. 2021 Jan 1;43(1):9-14. doi: 10.1097/DAD.0000000000001612. Am J Dermatopathol. 2021. PMID: 32149829 Review.
-
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022.Eur J Cancer. 2022 Jul;170:236-255. doi: 10.1016/j.ejca.2022.03.008. Epub 2022 May 12. Eur J Cancer. 2022. PMID: 35570085 Review.
References
-
- Malignant melanoma of unknown primary origin. Dasgupta T, Bowden L, Berg JW. https://pubmed.ncbi.nlm.nih.gov/14080349/ Surg Gynecol Obstet. 1963;117:341–345. - PubMed
-
- Scott JF, Gerstenblith MR. Noncutaneous Melanoma. Brisbane (AU): Codon Publications; 2018. Melanoma of unknown primary. - PubMed
-
- The many faces of completely regressed malignant melanoma. Barr RJ. https://pubmed.ncbi.nlm.nih.gov/9420907/ Pathology (Phila) 1994;2:359–370. - PubMed
-
- Expert recommendations on diagnostic-therapeutic management of melanoma patients. Rutkowski P, Wysocki PJ, Kozak K, et al. Oncology in Clinical Practice. 2009;18:357–392.
Publication types
LinkOut - more resources
Full Text Sources